Comparison of Eradication Rates Using Standard Triple Therapy and Sequential Therapy

Objectives The incidence of treatment failures following standard triple therapy (STT) for Helicobacter pylori eradication (HPE) has reached an unacceptable level. Sequential therapy (SQ) has emerged as a promising approach to counteract the escalation of antibiotic resistance. In this study, we use...

Full description

Bibliographic Details
Main Authors: Yuri Kim, Ji Yong Ahn, Hwoon-Yong Jung, Jin Hee Noh, Hee Kyong Na, Kee Wook Jung, Jeong Hoon Lee, Do Hoon Kim, Kee Don Choi, Ho June Song, Gin Hyug Lee
Format: Article
Language:English
Published: Yong Chan Lee 2023-12-01
Series:The Korean Journal of Helicobacter and Upper Gastrointestinal Research
Subjects:
Online Access:http://helicojournal.org/upload/pdf/kjhugr-2023-0042.pdf
_version_ 1797387641580158976
author Yuri Kim
Ji Yong Ahn
Hwoon-Yong Jung
Jin Hee Noh
Hee Kyong Na
Kee Wook Jung
Jeong Hoon Lee
Do Hoon Kim
Kee Don Choi
Ho June Song
Gin Hyug Lee
author_facet Yuri Kim
Ji Yong Ahn
Hwoon-Yong Jung
Jin Hee Noh
Hee Kyong Na
Kee Wook Jung
Jeong Hoon Lee
Do Hoon Kim
Kee Don Choi
Ho June Song
Gin Hyug Lee
author_sort Yuri Kim
collection DOAJ
description Objectives The incidence of treatment failures following standard triple therapy (STT) for Helicobacter pylori eradication (HPE) has reached an unacceptable level. Sequential therapy (SQ) has emerged as a promising approach to counteract the escalation of antibiotic resistance. In this study, we used a chronological cohort dataset to conduct a comparative analysis of the eradication rates, compliance, and adverse events associated with the 7-day STT and SQ. Methods A total of 789 patients underwent HPE treatment at Asan Medical Center between July 2013 and August 2017. Among them, 378 received a 7-day STT and 411 received a 10-day SQ. Baseline clinical data and treatment parameters were compared between the two treatment groups. Results SQ demonstrated an eradication rate of 84.7% (348/411), which was superior to that of the 7-day STT (74.1%; p<0.001). The incidence of adverse events was also higher in the SQ group than in the STT group (17.5% vs. 11.1%; p=0.01). Nonetheless, treatment compliance was not significantly different between the groups (98.1% [SQ] vs. 96.8% [STT]; p=0.38). Among the patients undergoing second-line eradication, the SQ group displayed a lower eradication rate than the STT group (77.8% vs. 92.4%; p=0.028). Notably, the overall eradication rate did not differ significantly between the two groups (98.3% [STT] vs. 97.4% [SQ]; p=0.56). Conclusions SQ exhibited superior efficacy compared with the 7-day STT as a first-line H. pylori treatment. Thus, SQ holds potential to serve as the replacement for the 7-day STT in treatment-naïve patients.
first_indexed 2024-03-08T22:28:57Z
format Article
id doaj.art-0923bab70c69476aa4a527dc6e84c51f
institution Directory Open Access Journal
issn 1738-3331
language English
last_indexed 2024-03-08T22:28:57Z
publishDate 2023-12-01
publisher Yong Chan Lee
record_format Article
series The Korean Journal of Helicobacter and Upper Gastrointestinal Research
spelling doaj.art-0923bab70c69476aa4a527dc6e84c51f2023-12-18T07:11:45ZengYong Chan LeeThe Korean Journal of Helicobacter and Upper Gastrointestinal Research1738-33312023-12-0123427728210.7704/kjhugr.2023.0042805Comparison of Eradication Rates Using Standard Triple Therapy and Sequential TherapyYuri Kim0Ji Yong Ahn1Hwoon-Yong JungJin Hee Noh2Hee Kyong Na3Kee Wook Jung4Jeong Hoon Lee5Do Hoon Kim6Kee Don Choi7Ho June Song8Gin Hyug Lee9 Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Asan Digestive Disease Research Institute, Seoul, Korea Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Asan Digestive Disease Research Institute, Seoul, Korea Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Asan Digestive Disease Research Institute, Seoul, Korea Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Asan Digestive Disease Research Institute, Seoul, Korea Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Asan Digestive Disease Research Institute, Seoul, Korea Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Asan Digestive Disease Research Institute, Seoul, Korea Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Asan Digestive Disease Research Institute, Seoul, Korea Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Asan Digestive Disease Research Institute, Seoul, Korea Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Asan Digestive Disease Research Institute, Seoul, Korea Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Asan Digestive Disease Research Institute, Seoul, KoreaObjectives The incidence of treatment failures following standard triple therapy (STT) for Helicobacter pylori eradication (HPE) has reached an unacceptable level. Sequential therapy (SQ) has emerged as a promising approach to counteract the escalation of antibiotic resistance. In this study, we used a chronological cohort dataset to conduct a comparative analysis of the eradication rates, compliance, and adverse events associated with the 7-day STT and SQ. Methods A total of 789 patients underwent HPE treatment at Asan Medical Center between July 2013 and August 2017. Among them, 378 received a 7-day STT and 411 received a 10-day SQ. Baseline clinical data and treatment parameters were compared between the two treatment groups. Results SQ demonstrated an eradication rate of 84.7% (348/411), which was superior to that of the 7-day STT (74.1%; p<0.001). The incidence of adverse events was also higher in the SQ group than in the STT group (17.5% vs. 11.1%; p=0.01). Nonetheless, treatment compliance was not significantly different between the groups (98.1% [SQ] vs. 96.8% [STT]; p=0.38). Among the patients undergoing second-line eradication, the SQ group displayed a lower eradication rate than the STT group (77.8% vs. 92.4%; p=0.028). Notably, the overall eradication rate did not differ significantly between the two groups (98.3% [STT] vs. 97.4% [SQ]; p=0.56). Conclusions SQ exhibited superior efficacy compared with the 7-day STT as a first-line H. pylori treatment. Thus, SQ holds potential to serve as the replacement for the 7-day STT in treatment-naïve patients.http://helicojournal.org/upload/pdf/kjhugr-2023-0042.pdf eradicationantibioticsstandard triple therapysequential therapy
spellingShingle Yuri Kim
Ji Yong Ahn
Hwoon-Yong Jung
Jin Hee Noh
Hee Kyong Na
Kee Wook Jung
Jeong Hoon Lee
Do Hoon Kim
Kee Don Choi
Ho June Song
Gin Hyug Lee
Comparison of Eradication Rates Using Standard Triple Therapy and Sequential Therapy
The Korean Journal of Helicobacter and Upper Gastrointestinal Research

eradication
antibiotics
standard triple therapy
sequential therapy
title Comparison of Eradication Rates Using Standard Triple Therapy and Sequential Therapy
title_full Comparison of Eradication Rates Using Standard Triple Therapy and Sequential Therapy
title_fullStr Comparison of Eradication Rates Using Standard Triple Therapy and Sequential Therapy
title_full_unstemmed Comparison of Eradication Rates Using Standard Triple Therapy and Sequential Therapy
title_short Comparison of Eradication Rates Using Standard Triple Therapy and Sequential Therapy
title_sort comparison of eradication rates using standard triple therapy and sequential therapy
topic
eradication
antibiotics
standard triple therapy
sequential therapy
url http://helicojournal.org/upload/pdf/kjhugr-2023-0042.pdf
work_keys_str_mv AT yurikim comparisonoferadicationratesusingstandardtripletherapyandsequentialtherapy
AT jiyongahn comparisonoferadicationratesusingstandardtripletherapyandsequentialtherapy
AT hwoonyongjung comparisonoferadicationratesusingstandardtripletherapyandsequentialtherapy
AT jinheenoh comparisonoferadicationratesusingstandardtripletherapyandsequentialtherapy
AT heekyongna comparisonoferadicationratesusingstandardtripletherapyandsequentialtherapy
AT keewookjung comparisonoferadicationratesusingstandardtripletherapyandsequentialtherapy
AT jeonghoonlee comparisonoferadicationratesusingstandardtripletherapyandsequentialtherapy
AT dohoonkim comparisonoferadicationratesusingstandardtripletherapyandsequentialtherapy
AT keedonchoi comparisonoferadicationratesusingstandardtripletherapyandsequentialtherapy
AT hojunesong comparisonoferadicationratesusingstandardtripletherapyandsequentialtherapy
AT ginhyuglee comparisonoferadicationratesusingstandardtripletherapyandsequentialtherapy